Victory Capital Management Inc. Trims Holdings in GE HealthCare Technologies Inc. $GEHC

Victory Capital Management Inc. decreased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.0% in the 3rd quarter, HoldingsChannel reports. The firm owned 833,584 shares of the company’s stock after selling 8,315 shares during the quarter. Victory Capital Management Inc.’s holdings in GE HealthCare Technologies were worth $62,602,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. True North Advisors LLC boosted its holdings in GE HealthCare Technologies by 2.0% in the third quarter. True North Advisors LLC now owns 6,987 shares of the company’s stock valued at $525,000 after purchasing an additional 139 shares in the last quarter. Klingman & Associates LLC raised its stake in shares of GE HealthCare Technologies by 4.0% during the 3rd quarter. Klingman & Associates LLC now owns 3,634 shares of the company’s stock worth $273,000 after buying an additional 139 shares in the last quarter. Colonial Trust Advisors lifted its stake in shares of GE HealthCare Technologies by 11.1% in the third quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock valued at $104,000 after purchasing an additional 139 shares during the period. Golden State Wealth Management LLC boosted its position in GE HealthCare Technologies by 7.4% during the second quarter. Golden State Wealth Management LLC now owns 2,138 shares of the company’s stock worth $158,000 after purchasing an additional 148 shares in the last quarter. Finally, Exchange Traded Concepts LLC lifted its holdings in shares of GE HealthCare Technologies by 1.3% in the third quarter. Exchange Traded Concepts LLC now owns 11,490 shares of the company’s stock valued at $863,000 after purchasing an additional 150 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 3.7%

Shares of NASDAQ:GEHC opened at $74.27 on Friday. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $89.77. The firm has a market cap of $33.85 billion, a P/E ratio of 16.29, a P/E/G ratio of 1.69 and a beta of 1.03. The company has a 50 day moving average of $81.81 and a 200-day moving average of $78.54.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. During the same quarter in the previous year, the company posted $1.45 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is 3.07%.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the stock. BTIG Research upped their price target on shares of GE HealthCare Technologies from $87.00 to $91.00 and gave the stock a “buy” rating in a research report on Wednesday, February 4th. Piper Sandler lifted their target price on GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a research report on Friday, January 30th. Wells Fargo & Company increased their price objective on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Wall Street Zen raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating in a report on Saturday. Finally, Citigroup boosted their target price on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Seven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $92.50.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.